Daily Morning Note – 5 April 2019

WEEKLY MARKET OUTLOOK WEBINAR

Register HERE for MONDAY’s 11.15am webinar.

Archived webinars available.

YOUR PHILLIP SUMMARY

The Dow Jones Industrial Average DJIA, +0.64% rose 166.50 points, or 0.6%, to 26,384.63, powered higher by shares of Boeing Inc. BA, +2.89% and Dow Inc. DOW, +4.98% . The S&P 500 index SPX, +0.21% added 5.99 points, or 0.2%, to 2,879.39, matching its six-day winning streak from February 2018. The Nasdaq Composite Index COMP, -0.05% bucked the trend to fall 3.77 points to 7,891.78. U.S.-China trade negotiations remain in the spotlight. Expectations for Washington and Beijing to resolve their differences have been cited as a driver of stock-market gains since late last year. President Donald Trump may announce plans for a summit with China’s President Xi Jinping as early as Thursday when he meets the country’s vice premier.



BREAKING NEWS

Brent oil briefly touches US$70/barrel on tight supply. Brent oil prices rose on Thursday, briefly touching US$70 a barrel for the first time since November as expectations of tight global supply outweighed pressure from rising US production and less robust global demand indicators. International benchmark Brent futures settled up 9 cents at US$69.40. Brent touched a session high of US$70.03, the highest since Nov 12 when it last traded above US$70. US West Texas Intermediate (WTI) crude fell 36 cents a barrel to settle at US$62.10. The contract hit US$62.99 on Wednesday, its highest since November.

HDB resale volume jumps 26.1% in March, prices inch up 0.2%: SRX. The volume of Housing Board (HDB) resale flats grew by 26.1 per cent in March, marking the highest jump in eight months since August last year. There were 1,657 HDB resale transactions in March, up from the 1,314 units sold in the previous month, according to according to flash estimates from real estate portal SRX Property on Thursday. However, resale volume in March was 12.7 per cent lower than the 1,897 units transacted in the same month last year.

Nomura axes 8 of 9 equity research jobs in Singapore in US$1b plan to cut costs. Nomura Holdings unveiled plans to cut US$1 billion of costs at its struggling investment bank, firing dozens and pulling back from businesses as it embarks on yet another sweeping overhaul of its international operations. Japan’s largest securities firm will cull about 150 jobs across the Americas and Europe, the Middle East and Africa on top of reductions in Hong Kong and Singapore as part of the overhaul, people with knowledge of the matter said. Eight out of nine employees in the Singapore equity research operation have been let go, the people said. Nomura also cut at least 10 jobs at its equities business in Hong Kong, one of the people said.

Lian Beng given 1-year extension to sell properties that may compete with subsidiary. Catalist property player SLB Development has obtained regulatory approval for its controlling shareholder Lian Beng Group to be given a one-year extension to dispose of competing business in Australia and Singapore. SLB, in a regulatory filing on Thursday, announced that unfavourable property market conditions Down Under and in the city-state have resulted in its parent company Lian Beng not being able to divest competing business by April this year. The deadline was a year from SLB’s Catalist debut in April 2018.

Frasers Property in talks to potentially sell Frasers Tower. Frasers Property said on Thursday that it “has been in discussions with certain parties who have expressed interest” in its Frasers Tower office property, located at 182 Cecil Street. It said that there is no certainty that any transaction would result from such discussions, according to a bourse filing in response to Bloomberg queries. Frasers Property also added that it continually reviews opportunities to enhance shareholder value. This includes potential opportunities to collaborate with new investors, as well as divesting its interests in projects or assets.

Distressed Hyflux says Salim-Medco rescue is off; but investor ‘surprised’ by news. Cash-strapped Hyflux said on Thursday that a key rescue deal from the Salim-Medco investment group is officially off with just weeks to go before the water and power plant company loses court protection from creditors. Hyflux has cancelled scheme meetings scheduled for April 5 and 8. There is also no need for shareholders to attend an extraordinary general meeting scheduled for April 15, the company said.

Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

Disclaimer
The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.

 

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com